Back
 Health  Vol.8 No.13 , October 2016
Study of Hepatitis B Virus Genotypes and Mutation in 1762 & 1764 Nucleotides of X Gene in Chronic HBV Patients from Golestan Province—Iran
Abstract: Introduction: More than 350 million people are chronic carriers of HBV and many of them develop progressive diseases, including cirrhosis and hepatocellular carcinoma. Many of those infected develop persistent disease and a proportion goes on to develop liver failure and cancer. Researchers showed that double mutations of the x gene at position 1762 and 1764, have been found in chronic hepatitis B. These mutations were proposed to be associated with fulminant hepatitis B increasing risk of hepatocellular carcinoma. This project aimed to investigate mutation in the x gene region of HBV infected patients in Golestan province, Iran. Method: 100 patients were entered in this study. Hepatitis B viral DNA was extracted from plasma and PCR was performed using specific primers. Direct sequencing and alignment of x gene were applied using reference sequence from Gene Bank database (Okamoto, 1988; Accession number AB033559). Results: Among the chronic HBV patients 51% were male. The results showed that 49% of patients had A1762T, G1764A mutations changing AGG to stop codon TGA. 27% and 24% of cases were showed mutation only in A1762T and G1764A positions respectively. Conclusion: This study was shown presence of X gene mutation in HBV infected people in Golestan province, Iran. The rate of mutation in two positions 1762 and 1764 of HBV genotype D X gene was higher than the average rate of the world (34%).
Cite this paper: Zhand, S. , Rostamian, G. , Tabarraei, A. and Moradi, A. (2016) Study of Hepatitis B Virus Genotypes and Mutation in 1762 & 1764 Nucleotides of X Gene in Chronic HBV Patients from Golestan Province—Iran. Health, 8, 1397-1401. doi: 10.4236/health.2016.813140.
References

[1]   Ataollahi, M.R., Daneshian, M., Paknahad, M.R., Paknahad, S., Pouraskar, M. and Paknahad, A. (2016) Hepatitis B and Its Related Factors: A Review.

[2]   Kao, J.H., Chen, P.J., Lai, M.Y. and Chen, D.S. (2003) Basal Core Promoter Mutations of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma in Hepatitis B Carriers. Gastroenterology, 124, 327-334. http://dx.doi.org/10.1053/gast.2003.50053

[3]   Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., et al. (2009) Associations between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis. Journal of the National Cancer Institute, 101, 1066-1082. http://dx.doi.org/10.1093/jnci/djp180

[4]   Hunt, C.M., McGill, J.M., Allen, M.I. and Condreay, L.D. (2000) Clinical Relevance of Hepatitis B Viral Mutations. Hepatology, 31, 1037-1044.
http://dx.doi.org/10.1053/he.2000.6709

[5]   Kidd-Ljunggren, K., Oberg, M. and Kidd, A. (1997) Hepatitis B Virus X Gene 1751 to 1764 Mutations: Implications for HBeAg Status and Disease. Journal of General Virology, 78, 1469-1478. http://dx.doi.org/10.1099/0022-1317-78-6-1469

[6]   Erhardt, A., Reineke, U., Blondin, D., Gerlich, W.H., Adams, O., Heintges, T., et al. (2000) Mutations of the Core Promoter and Response to Inter-feron Treatment in Chronic Replicative Hepatitis B. Hepatology, 31, 716-725. http://dx.doi.org/10.1002/hep.510310323

[7]   Hussain, M., Chu, C.-J., Sablon, E. and Lok, A.S. (2003) Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants. Journal of Clinical Microbiology, 41, 3699-3705.
http://dx.doi.org/10.1128/JCM.41.8.3699-3705.2003

[8]   Alavian, S.M., Fallahian, F. and Lankarani, K.B. (2007) The Changing Epidemiology of Viral Hepatitis B in Iran. Journal of Gastrointestinal and Liver Diseases, 16, 403.

[9]   Gholamreza, R., Shahryar, S., Abbasali, K., Hamidreza, J., Abdolvahab, M., Khodaberdi, K., et al. (2007) Seroprevalence of Hepatitis B Vi-rus and Its Co-Infection with Hepatitis D Virus and Hepatitis C Virus in Iranian Adult Population. Indian Journal of Medical Sciences, 61, 263. http://dx.doi.org/10.4103/0019-5359.32092

[10]   Okamoto, H., Tsuda, F., Akahane, Y., Sugai, Y., Yoshiba, M., Moriyama, K., et al. (1994) Hepatitis B Virus with Mutations in the Core Promoter for an e Antigen-Negative Phenotype in Carriers with Antibody to e Antigen. Journal of Virology, 68, 8102-8110.

[11]   Parekh, S., Zoulim, F., Ahn, S.H., Tsai, A., Li, J., Kawai, S., et al. (2003) Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants. Journal of Virology, 77, 6601-6612.
http://dx.doi.org/10.1128/JVI.77.12.6601-6612.2003

[12]   Liu, C.-J., Chen, B.-F., Chen, P.-J., Lai, M.-Y., Huang, W.-L., Kao, J.-H., et al. (2006) Role of Hepatitis B Viral Load and Basal Core Promoter Mutation in Hepatocellular Carcinoma in Hepatitis B Carriers. Journal of Infectious Diseases, 193, 1258-1265.
http://dx.doi.org/10.1086/502978

[13]   Lee, J.-H., Han, K.-H., Lee, J.M., Park, J.H. and Kim, H.-S. (2013) Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection. Clinical and Vaccine Immunology, 20, 127.
http://dx.doi.org/10.1128/CVI.00661-12

[14]   Yan, T., Li, K., Su, H., Liu, X., Zang, H. and Wang, H. (2010) Analysis the Relationship of HBV BCP A1762T/G1764A Double Mutation with HBV Related Acute on Chronic Liver Failure. Chinese Journal of Experimental and Clinical Virology, 24, 190-192.

 
 
Top